An early stage pulmonary medical device company has developed a breath sensor to measure air speed, which helps diagnose lung disease.
The company’s device offers a more cost-effective option to the more expensive technology currently being used by pulmonary medical instruments to measure air flow, according to a company statement. Its FeatherTone Sensor would focus on asthma and chronic obstructive pulmonary disease patients, a market of more than 19 million people.
Dr. Ned Forbes, the co-founder of Millville, New Jersey-based Feather Sensors, said the company recently signed an agreement with Taiyo Instruments to distribute the device in Japan and projects first-year sales at $100,000. In three years, it expects that number to grow to $2 million. Forbes runs the company with Dr. Robert E. Coifman, an allergist. Forbes spoke to MedCity News at a conference this week on personalized medicine in Princeton, New Jersey, which was hosted by biotechnology industry association BioNJ.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Dr. Ned Forbes of Feather Sensors
